Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia

Completed · Phase 2 · Has a placebo group

Conditions studied: Schizophrenia

In brief

The purpose of this study is to determine whether a low dose and a high dose of the study drug SCA-136 are effective and safe in the treatment of schizophrenia requiring hospitalization.

Key facts

Study ID

NCT00265551

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

300

Starts

2006-01-01

Expected to finish

2007-01-01

Last updated by the study team

2007-12-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of schizophrenia
• Ability to remain hospitalized for at least first 4 weeks of study
• Needs hospitalization due to worsening of schizophrenia

You may not qualify if…

• Type 1 or 2 diabetes
• Previous use of clozapine
• Serious medical illness other than schizophrenia

Where it is running

• Study site — Little Rock, Arkansas, United States
• Study site — Cerritos, California, United States
• Study site — Costa Mesa, California, United States
• Study site — La Mesa, California, United States
• Study site — Oceanside, California, United States
• Study site — Paramount, California, United States
• Study site — Pico Rivera, California, United States
• Study site — Rosemead, California, United States
• Study site — San Diego, California, United States
• Study site — San Diego, California, United States
• Study site — Torrance, California, United States
• Study site — Middletown, Connecticut, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Fort Lauderdale, Florida, United States
• Study site — Kissimmee, Florida, United States
• Study site — North Miami, Florida, United States
• Study site — Hoffman Estates, Illinois, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Lake Charles, Louisiana, United States
• Study site — Baltimore, Maryland, United States
• Study site — Rockville, Maryland, United States
• Study site — St Louis, Missouri, United States
• Study site — Willingboro, New Jersey, United States
• Study site — Cedarhurst, New York, United States
• Study site — Holliswood, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.